Jonathan C. Fox - 01 Jul 2025 Form 4 Insider Report for Edgewise Therapeutics, Inc. (EWTX)

Role: Director
Signature: /s/ John R. Moore, Attorney-in-Fact for Fox Jonathan C
Issuer symbol: EWTX
Transactions as of: 01 Jul 2025
Net transactions value: $0
Form type: 4
Filing time: 02 Jul 2025, 16:18:34 UTC
Previous filing: 18 Jun 2025
Next filing: 02 Oct 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Fox Jonathan C	Director	C/O EDGEWISE THERAPEUTICS, INC., 1715 38TH STREET, BOULDER	/s/ John R. Moore, Attorney-in-Fact for Fox Jonathan C	02 Jul 2025	0001655016

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EWTX	Common Stock	Award	$0	+858	+7.5%	$0.000000	12,274	01 Jul 2025	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Consists of restricted stock units, each of which represent a contingent right to receive one share of Edgewise Therapeutics, Inc. (the "Issuer") common stock, granted and released to the reporting person on July 1, 2025, as a Quarterly Retainer Award pursuant to Section 2.4 of the the Issuer's Outside Director Compensation Policy, as amended.